Just saw Druckenmiller's latest 13F filing and there's some interesting portfolio moves worth talking about. The guy basically took profits on two of his best performers this quarter -- Teva Pharma and Taiwan Semi -- both stocks that had basically doubled since he picked them up last year.

Teva's been performing well under new leadership, focusing more on high-margin drug development rather than just cutting costs. TSMC, well, that's riding the AI wave as the world's top chip fabricator. But here's the thing -- with an average holding period of just 7.5 months in his $4.5 billion portfolio, when something's up 100%, you ring the bell and take your chips off the table. Classic profit-taking move.

What caught my attention though was where he's rotating that capital. Druckenmiller just bought over 5.4 million shares of the financial sector ETF (XLF) and made it his fund's number two holding. That's roughly $301 million going into financials, which is kind of a statement about where he thinks the economy's headed.

Now, financial stocks typically do better when rates are rising -- higher rates mean better margins for banks and lenders. The Fed's been cutting rates since September, so on the surface that seems counterintuitive. But I think the read here is that Druckenmiller might be positioning for inflation concerns or expecting the Fed to pause or even reverse course down the road. If that happens, financial stocks could perform really well.

It's a smart co-allocation strategy honestly -- book the wins on the semiconductor and pharma plays that already ran hard, then pivot to a sector that could benefit if the macro environment shifts. That's how top performers stay on top of the market.